{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,3]],"date-time":"2026-06-03T00:13:49Z","timestamp":1780445629200,"version":"3.54.1"},"reference-count":14,"publisher":"Springer Science and Business Media LLC","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2020,8,27]]},"DOI":"10.7759\/cureus.10077","type":"journal-article","created":{"date-parts":[[2020,8,27]],"date-time":"2020-08-27T17:50:43Z","timestamp":1598550643000},"source":"Crossref","is-referenced-by-count":1,"title":["Who Watches the \u201cWatchman\u201d and How Often?"],"prefix":"10.7759","author":[{"given":"Kyaw M","family":"Hlaing","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thein T","family":"Aung","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kevin","family":"Kravitz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kamran","family":"Riaz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","reference":[{"key":"ref1","doi-asserted-by":"publisher","DOI":"10.1161\/CIR.0000000000000350","article-title":"Executive summary: heart disease and stroke statistics\u20142016 update","volume":"133","author":"Writing Group Members","year":"2016","unstructured":"Writing Group Members, Mozaffarian D, Benjamin EJ, et al.. Executive summary: heart disease and stroke statistics\u20142016 update. Circulation. 2016, 133:38-360.  10.1161\/CIR.0000000000000350","journal-title":"Circulation"},{"key":"ref2","doi-asserted-by":"publisher","DOI":"10.1016\/0003-4975(95)00887-X","article-title":"Appendage obliteration to reduce stroke in cardiac surgical patients with atrial fibrillation","volume":"61","author":"Blackshear JL","year":"1996","unstructured":"Blackshear JL, Odell JA. Appendage obliteration to reduce stroke in cardiac surgical patients with atrial fibrillation. Ann Thorac Surg. 1996, 61:755-759. 10.1016\/0003-4975(95)00887-X","journal-title":"Ann Thorac Surg"},{"key":"ref3","doi-asserted-by":"publisher","DOI":"10.1378\/chest.09-1584","article-title":"Refining clinical risk stratification for predicting stroke and thromboembolism in atrial fibrillation using a novel risk factor-based approach: the Euro Heart Survey on atrial fibrillation","volume":"137","author":"Lip GY","year":"2010","unstructured":"Lip GY, Nieuwlaat R, Pisters R, Lane DA, Crijns HJ. Refining clinical risk stratification for predicting stroke and thromboembolism in atrial fibrillation using a novel risk factor-based approach: the Euro Heart Survey on atrial fibrillation. Chest. 2010, 137:263-272. 10.1378\/chest.09-1584","journal-title":"Chest"},{"key":"ref4","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(13)62343-0","article-title":"Comparison of the efficacy and safety of new oral anticoagulants with warfarin in patients with atrial fibrillation: a meta-analysis of randomised trials","volume":"15","author":"Ruff CT","year":"2014","unstructured":"Ruff CT, Giugliano RP, Braunwald E, et al.. Comparison of the efficacy and safety of new oral anticoagulants with warfarin in patients with atrial fibrillation: a meta-analysis of randomised trials. Lancet. 2014, 15:955-962. 10.1016\/S0140-6736(13)62343-0","journal-title":"Lancet"},{"key":"ref5","article-title":"Oral anticoagulant discontinuation in patients with nonvalvular atrial fibrillation","volume":"1","author":"Kachroo S","year":"2016","unstructured":"Kachroo S, Hamilton M, Liu X, Pan X, Brixner D, Marrouche N, Biskupiak J. Oral anticoagulant discontinuation in patients with nonvalvular atrial fibrillation. Am J Manag Care. 2016, 1:1-8.","journal-title":"Am J Manag Care"},{"key":"ref6","doi-asserted-by":"publisher","DOI":"10.1161\/CIRCULATIONAHA.112.114389","article-title":"Percutaneous left atrial appendage closure for stroke prophylaxis in patients with atrial fibrillation: 2.3-year follow-up of the PROTECT AF (Watchman Left Atrial Appendage System for Embolic Protection in Patients with Atrial Fibrillation) Trial","volume":"12","author":"Reddy VY","year":"2013","unstructured":"Reddy VY, Doshi SK, Sievert H, et al.. Percutaneous left atrial appendage closure for stroke prophylaxis in patients with atrial fibrillation: 2.3-year follow-up of the PROTECT AF (Watchman Left Atrial Appendage System for Embolic Protection in Patients with Atrial Fibrillation) Trial. Circulation. 2013, 12:720-729. 10.1161\/CIRCULATIONAHA.112.114389","journal-title":"Circulation"},{"key":"ref7","doi-asserted-by":"publisher","DOI":"10.1016\/j.jacc.2016.10.010","article-title":"Post-approval U.S. experience with left atrial appendage closure for stroke prevention in atrial fibrillation","volume":"24","author":"Reddy VY","year":"2017","unstructured":"Reddy VY, Gibson DN, Kar S, et al.. Post-approval U.S. experience with left atrial appendage closure for stroke prevention in atrial fibrillation. J Am Coll Cardiol. 2017, 24:253-261. 10.1016\/j.jacc.2016.10.010","journal-title":"J Am Coll Cardiol"},{"key":"ref8","doi-asserted-by":"publisher","DOI":"10.1016\/j.jcin.2016.09.041","article-title":"With the hounds: Watchman device surgical resection in the setting of recurrent device related thrombi in a patient with bleeding diathesis","volume":"9","author":"O'Hara C","year":"2016","unstructured":"O'Hara C, O'Hara GE, Jacques F, et al.. With the hounds: Watchman device surgical resection in the setting of recurrent device related thrombi in a patient with bleeding diathesis. JACC Cardiovasc Interv. 2016, 9:223-225. 10.1016\/j.jcin.2016.09.041","journal-title":"JACC Cardiovasc Interv"},{"key":"ref9","doi-asserted-by":"publisher","DOI":"10.1097\/MD.0000000000008693","article-title":"WATCHMAN device-related thrombus successfully treated with apixaban: a case report","volume":"96","author":"Wong CK","year":"2017","unstructured":"Wong CK, Chan PH, Lam CC, Kwok OH, Lam YY, Siu CW. WATCHMAN device-related thrombus successfully treated with apixaban: a case report. Medicine. 2017, 96:8693. 10.1097\/MD.0000000000008693","journal-title":"Medicine"},{"key":"ref10","doi-asserted-by":"publisher","DOI":"10.1016\/j.amjcard.2016.01.039","article-title":"Assessment of device-related thrombus and associated clinical outcomes with the WATCHMAN left atrial appendage closure device for embolic protection in patients with atrial fibrillation (from the PROTECT-AF Trial)","volume":"117","author":"Main ML","year":"2016","unstructured":"Main ML, Fan D, Reddy VY, et al.. Assessment of device-related thrombus and associated clinical outcomes with the WATCHMAN left atrial appendage closure device for embolic protection in patients with atrial fibrillation (from the PROTECT-AF Trial). Am J Cardiol. 2016, 117:1127-1134. 10.1016\/j.amjcard.2016.01.039","journal-title":"Am J Cardiol"},{"key":"ref11","doi-asserted-by":"publisher","DOI":"10.1161\/CIRCULATIONAHA.118.035090","article-title":"Device-related thrombus after left atrial appendage closure: incidence, predictors, and outcomes","volume":"138","author":"Dukkipati SR","year":"2018","unstructured":"Dukkipati SR, Kar S, Holmes DR Jr, et al.. Device-related thrombus after left atrial appendage closure: incidence, predictors, and outcomes. Circulation. 2018, 138:874-885. 10.1161\/CIRCULATIONAHA.118.035090","journal-title":"Circulation"},{"key":"ref12","doi-asserted-by":"publisher","DOI":"10.1016\/j.jacep.2017.05.006","article-title":"Incidence, characteristics, and clinical course of device-related thrombus after Watchman left atrial appendage occlusion device implantation in atrial fibrillation patients","volume":"3","author":"Kubo S","year":"2017","unstructured":"Kubo S, Mizutani Y, Meemook K, Nakajima Y, Hussaini A, Kar S. Incidence, characteristics, and clinical course of device-related thrombus after Watchman left atrial appendage occlusion device implantation in atrial fibrillation patients. JACC Clin Electrophysiol. 2017, 3:1380-1386. 10.1016\/j.jacep.2017.05.006","journal-title":"JACC Clin Electrophysiol"},{"key":"ref13","doi-asserted-by":"publisher","DOI":"10.1161\/CIRCULATIONAHA.118.035090","article-title":"Device-related thrombus after left atrial appendage closure: incidence, predictors, and outcomes","volume":"138","author":"Dukkipati SR","year":"2018","unstructured":"Dukkipati SR, Kar S, Holmes DR, et al.. Device-related thrombus after left atrial appendage closure: incidence, predictors, and outcomes. Circulation. 2018, 138:874-885. 10.1161\/CIRCULATIONAHA.118.035090","journal-title":"Circulation"},{"key":"ref14","doi-asserted-by":"publisher","DOI":"10.1016\/j.jcin.2010.04.017","article-title":"Left atrial appendage obliteration: mechanisms of healing and intracardiac integration","volume":"3","author":"Schwartz RS","year":"2010","unstructured":"Schwartz RS, Holmes DR, Van Tassel RA, et al.. Left atrial appendage obliteration: mechanisms of healing and intracardiac integration. JACC Cardiovasc Interv. 2010, 3:870-877. 10.1016\/j.jcin.2010.04.017","journal-title":"JACC Cardiovasc Interv"}],"container-title":["Cureus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cureus.com\/articles\/39399-who-watches-the-watchman-and-how-often","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,2,9]],"date-time":"2024-02-09T19:21:48Z","timestamp":1707506508000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cureus.com\/articles\/39399-who-watches-the-watchman-and-how-often"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,8,27]]},"references-count":14,"URL":"https:\/\/doi.org\/10.7759\/cureus.10077","relation":{},"ISSN":["2168-8184"],"issn-type":[{"value":"2168-8184","type":"print"}],"subject":[],"published":{"date-parts":[[2020,8,27]]}}}